- Home
- NOTE vs LXRX Comparison
NOTE vs LXRX Comparison
Compare NOTE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- LXRX
- Stock Information
- Founded
- NOTE 2013
- LXRX 1995
- Country
- NOTE United States
- LXRX United States
- Employees
- NOTE N/A
- LXRX N/A
- Industry
- NOTE EDP Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- LXRX Health Care
- Exchange
- NOTE Nasdaq
- LXRX Nasdaq
- Market Cap
- NOTE 133.5M
- LXRX 124.4M
- IPO Year
- NOTE N/A
- LXRX 2000
- Fundamental
- Price
- NOTE $0.79
- LXRX $0.46
- Analyst Decision
- NOTE Strong Buy
- LXRX Buy
- Analyst Count
- NOTE 6
- LXRX 4
- Target Price
- NOTE $2.80
- LXRX $3.67
- AVG Volume (30 Days)
- NOTE 1.8M
- LXRX 30.7M
- Earning Date
- NOTE 03-13-2025
- LXRX 03-06-2025
- Dividend Yield
- NOTE N/A
- LXRX N/A
- EPS Growth
- NOTE N/A
- LXRX N/A
- EPS
- NOTE 0.07
- LXRX N/A
- Revenue
- NOTE $120,266,000.00
- LXRX $31,081,000.00
- Revenue This Year
- NOTE N/A
- LXRX N/A
- Revenue Next Year
- NOTE $42.32
- LXRX $101.91
- P/E Ratio
- NOTE $11.41
- LXRX N/A
- Revenue Growth
- NOTE N/A
- LXRX 2481.48
- 52 Week Low
- NOTE $0.75
- LXRX $0.28
- 52 Week High
- NOTE $2.07
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- NOTE 31.40
- LXRX 50.39
- Support Level
- NOTE $0.93
- LXRX $0.32
- Resistance Level
- NOTE $1.08
- LXRX $0.71
- Average True Range (ATR)
- NOTE 0.09
- LXRX 0.06
- MACD
- NOTE -0.01
- LXRX 0.03
- Stochastic Oscillator
- NOTE 3.30
- LXRX 36.95
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.